Business
Vanda Pharmaceuticals Announces Presentations at SLEEP 2023
WASHINGTON, June 1, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2023, to be held in
About this update from Vanda Pharmaceuticals Inc.
[{"type":"text","content":"WASHINGTON, June 1, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2023, to be held in Indianapolis, IN from June 3 – 7, 2023.\nThe following will be presented:\nJune 5, 2023\nPresentation Title: \"Melanopsin Genetic Variants and Delayed Sleep Phenotype – Whole Genome Sequencing Analysis\" Poster Number: 94 Presenter: Dr. Sandra Paulina Smieszek, Head of Genetics Poster Session Presentation Time: 5:00 PM – 6:00 PM ET\nJune 6, 2023\nPresentation Title: \"Dim Light Melatonin Onset Analysis in Individuals Diagnosed with Delayed Sleep-Wake Phase Disorder (DSWPD)\" Poster Number: 307 Presenter: Dr. Sandra Paulina Smieszek, Head of Genetics Poster Session Presentation Time: 12:00 PM – 1:15 PM ET\nPresentation Title: \"Effect of Iloperidone on Sleep Symptoms in Bipolar Patients with Manic and Mixed Episodes: A Randomized, Placebo Controlled Study\" Poster Number: 372 Presenter: Dr. Sandra Paulina Smieszek, Head of Genetics Poster Session Presentation Time: 5:00 PM – 6:00 PM ET\nFor more information on SLEEP 2023, please refer to https://www.sleepmeeting.org/.\nAbout Vanda Pharmaceuticals Inc.\nVanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.\nCorporate Contact:Kevin MoranSenior Vice President, Chief Financial Officer and Treasurer Vanda Pharmaceuticals Inc. 202-734-3400 [email protected]\nElizabeth Van Every Head of Corporate Affairs Vanda Pharmaceuticals Inc. 202-734-3400 [email protected]\n View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-presentations-at-sleep-2023-301840794.html\nSOURCE Vanda Pharmaceuticals Inc.","length":3637,"tagName":"div"}]